Page 4 - Granules India
Granules acquires exclusive product rights from US pharma company
Windlas through its subsidiaries holds Abbreviated New Drug Applications (ANDAs) for Fingolimod, Prasugrel, Dronedarone and Lurasidone
 "Granules acquires exclusive product rights from US pharma company")
Updated On : 09 Jun 2016 | 12:23 PM IST
Granules India gets establishment inspection report from USFDA
For the inspection done at the company's Jeedimetla plant in Telangana
 "Granules India gets establishment inspection report from USFDA")
Updated On : 30 May 2016 | 4:20 PM IST
